A Potential Marker Of Increased Histological Activity In Hepatitis C Virus Infection
Main Category: Liver Disease / HepatitisArticle Date: 18 Feb 2009 - 2:00 PDT
Early, vigorous and sustained lymphocyte proliferative responses specific to hepatitis C virus (HCV) have been regarded as pivotal for viral clearance. On the other hand, antibody responses' contribution is still controversial. Research data have been accumulated regarding the significance of specific antibody classes during chronic infection. Particularly, the relation of IgA and alcohol-induced hepatic damage has been recognized, but its possible implication in HCV chronic infection has not been explored so far.
A research article published on November 28, 2008 in the World Journal of Gastroenterology addresses this question. This article investigated the HCV-specific immune responses in chronic treated and untreated patients, in paired samples taken 6 months apart. IgG, IgM and IgA levels, as well as IgG1-4 subclasses and peripheral blood lymphocyte proliferative responses against core, envelope and NS3 antigens were assayed by ELISA and CFSE staining, respectively.
Over 70% of the patients showed specific IgG and IgM against HCV capsid, E1 and NS3, while the hypervariable region-1 of E2 was recognized by half of patients. Anti-capsid IgM and IgG levels increased over time, while IgA levels did not; instead, an increase in IgA positive samples was observed. Particularly, IgA against HCV structural antigens positively correlated with necro-inflammatory activity. IgG subclasses evaluation against capsid and NS3 revealed that more than 80% of the individuals were positive for IgG1. On the contrary, less than 30% of the patients showed a positive proliferative response of CD4+ and CD8+ T cells, the viral capsid being poorly recognized.
Correlation analysis between demographic variables and humoral response revealed that alcohol consumption was negatively correlated with the responses of the main classes IgM, IgA and IgG, as well as IgG4. On the other hand, presence of specific IgG4 positively correlated with the fact of being treated with the standard therapy and the grade of necro-inflammatory activity. Additionally, the necro-inflammatory activity, also correlated with IgA, while fibrosis did not.
These results confirm that while the cellular immune response is weak and narrow, a broad and vigorous humoral response is present in chronic HCV infection. Particularly, the association of specific IgA response to necro-inflammatory activity paves the way to further studies to confirm its usefulness as a non-invasive, easy-to-measure marker of histological activity in chronic HCV infection.
###
Reference: Amador-Cañizares Y, Alvarez-Lajonchere L, Guerra I, Rodríguez- Alonso I, Martínez-Donato G, Triana J, González-Horta EE, Pérez A, Dueñas-Carrera S. Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C. World J Gastroenterol 2008; 14(44): 6844-6852
http://www.wjgnet.com/1007-9327/14/6844.asp
Correspondence to: Yalena Amador-Cañizares, HCV Department, Vaccine Division, Centro de Ingeniería Genética y Biotecnología, Ave 31, 58 and 190, Playa, PO Box 6162, Havana, Cuba.
Source: Lin Tian
World Journal of Gastroenterology
Visit our liver disease / hepatitis section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/139330.php>
APA
http://www.medicalnewstoday.com/releases/139330.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Thanks for informative web site
posted by Jennifer Klein on 18 Feb 2009 at 11:50 amI just wanted to say thank you for such an informative web site. You really help a lot of people out there by sharing. Keep up the great work! :)
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




